Clinical Trial Update: ORAL T-6: Oral Androgens in Man-6 [Phase 1]

View source ↗

Summary

Phase 1 trial of ORAL T-6, an oral androgen studied in men for contraception and hypogonadism, has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• Oral T-6

Snippet

Sponsor: University of Washington | Conditions: Contraception, Hypogonadism | Phase 1 | Status: COMPLETED | Results posted: 2011-01-24